Kimberly L. Sterling
Vice President of Global Value & Access, ResMed
Dr. Kimberly L. Sterling is the Vice President of Global Value & Access at ResMed. Kimberly serves as a key leader within the Medical Affairs organization, responsible for the market access strategy and development of scientific evidence that demonstrates the value of ResMed device and digital solutions, with a significant focus on research that supports gaining, maintaining, and expanding patient and provider access. In her leadership role, she engages as an internal champion of diversity, equity, inclusion and belonging within and beyond Medical Affairs. She also is an influential thought leader working alongside external industry organizations that are working to empower diverse communities and eliminate health inequities.
Prior to joining ResMed in 2019, Kimberly held a variety of positions at Eli Lilly & Company and Sanofi, focused on HEOR strategy & implementation, scientific communication to payers and engagement with health technology assessment organizations. She has more than 20 years of HEOR experience within the pharmaceutical and medical device industries. Kimberly received her Doctor of Pharmacy degree from Butler University then went on to receive her Master of Science degree in Pharmaceutical Economics and Policy at the University of Southern California. In addition to her current sleep and respiratory medicine research at ResMed, she has published HEOR studies for multiple other diseases including bipolar disorder, cardiovascular diseases, diabetes, and autoimmune diseases in peer-reviewed journals.
1 blog from the author
Posted on 27.06.2023
The European Health Data Space (EHDS): The Promise of Secondary Use of Data for Healthcare Innovation
The European Health Data Space (EHDS) regulation proposes a framework that would allow for the secure and efficient use of health data for research, innovation, policy-making, and regulatory activities. This type of framework for the ‘secondary use’ of health data has the potential to deliver new and meaningful insights that inform research and innovation, ultimately […]